Building 12 Communications, LLC Press Releases - EIN Presswire

Published on January 24, 2024 - 15:00 GMT

ThinkCyte collaborates with joint research group to advance development of stem cell-based therapies

A new publication in the January 4 issue of Stem Cell Reports on a method to improve pluripotent stem cell-based therapies for retinal degenerative diseases TOKYO, JAPAN, January 24, 2024 /⁨EINPresswire.com⁩/ -- ThinkCyte today announced the publication …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 9, 2024 - 17:28 GMT

ThinkCyte Launches Partnering Platform

ThinkCyte today announced the launch of its new partnering program for the biopharmaceutical and diagnostics industry. TOKYO, JAPAN, January 9, 2024 /⁨EINPresswire.com⁩/ -- ThinkCyte today announced the launch of its new partnering program for the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 28, 2023 - 17:30 GMT

ThinkCyte Secures $24 million in Funding to Accelerate Growth

ThinkCyte today announced the successful completion of a funding round, raising $24 million USD (approx. JPY 3.3 billion). TOKYO, JAPAN, November 28, 2023 /⁨EINPresswire.com⁩/ -- ThinkCyte today announced the successful completion of a funding round, …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 18, 2023 - 15:00 GMT

ThinkCyte Awarded NEDO's Deep Tech Startup Support Funding

NEDO's DTSU is a Japanese national research and development agency that supports the advancement of innovative technologies. TOKYO, JAPAN, October 18, 2023 /⁨EINPresswire.com⁩/ -- ThinkCyte today announced it has been awarded the DMP (Demonstration …

Distribution channels: Science ...

Published on July 22, 2021 - 15:16 GMT

Applied Cells Inc. Introduces the Offering of MARS® MAG Line Reagents for Complete Turnkey Solutions to Cell Isolation.

MARS® Systems and MARS® MAG Line purifies target cells in a rapid, automated, flexible process with a cost-effective solution. SANTA CLARA, CA, USA, July 22, 2021 /⁨EINPresswire.com⁩/ -- Applied Cells, a provider of cell preparation and isolation …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on April 26, 2021 - 02:30 GMT

Applied Cells Inc. Enters Collaborative Research Agreement for Rare Cell Isolation in Minimum Residual Disease.

Detection of Disseminating Tumor Cells (DTCs) in bone marrow holds promise for the early detection of potential relapse, decreasing overall survival rate. SANTA CLARA, CALIFORNIA, UNITED STATES, April 25, 2021 /⁨EINPresswire.com⁩/ -- Applied Cells, Inc., …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 22, 2021 - 17:58 GMT

Applied Cells, Inc. Announces the Expansion of the Global Distributor Network in Asia and Scandinavia for MARS®

Has signed agreements with international distributors covering Northern and Southern China, Korea, Scandinavia and the Baltics for the MARS® System. SANTA CLARA, CA, UNITED STATES, March 22, 2021 /⁨EINPresswire.com⁩/ -- Applied Cells, Inc., today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on December 4, 2020 - 09:03 GMT

Applied Cells, Inc. Announces the Addition of Two New Global Distributors in Switzerland and Australia New Zealand

Applied Cells, Inc., today announced it has signed agreements with two international distributors for its proprietary MARS® Platform. SANTA CLARA, CA, UNITED STATES, December 4, 2020 /⁨EINPresswire.com⁩/ -- Applied Cells, Inc., today announced it has …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...